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Introduction
Although the mortality rates for acute myocardial infarc-
tion (AMI) and stroke in older patients have decreased
in recent years1, AMI and stroke are still leading causes
of death for elderly people in Taiwan. AMI and stroke
are also major contributors to medical expenditure in
many countries. In the United States, more than 200,000
cases older than 65 years are admitted annually for
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SUMMARY
Background: Stroke and acute myocardial infarction (AMI) are serious diseases for elderly patients in Taiwan.
For better outcomes, we prepared guidelines for the transfer of these patients to major medical centers.
However, there has been no evidence-based research conducted in Taiwan focusing on the mortality rate 
of elderly AMI and stroke patients in different levels of hospital. The purpose of our study was to evaluate the
outcomes for elderly stroke and AMI patients in different levels of hospitals.
Methods: From the original claim data of 1 million beneficiaries enrolled in 2007, all hospitalized patients
older than 50 years with the primary diagnosis of AMI, hemorrhagic stroke, or ischemic stroke (ICD-9-CM code
410, 430–432, or 433–438) were identified from the database. In 2007, 338 AMI cases, 293 hemorrhagic stroke
cases, and 1,290 ischemic stroke cases were included in our study. Patients who were transferred between hospitals
were excluded. All the possible risk factors such as patient age, sex, triage classification, preexisting comorbidities,
and different hospital levels were adjusted for in a logistic regression model.
Results: In ischemic stroke patients, the odds ratio of mortality for the patients in major medical centers was
0.4 times that for patients in regional hospitals. Thus, major medical centers were safer for ischemic stroke
patients after adjusting for patient age, sex, triage classifications and preexisting comorbidities. However, dif-
ferences in the survival rates of hemorrhagic stroke patients between hospitals were insignificant. In AMI
patients, the survival rates were also not significantly different after adjusting for age, sex, triage classification,
preexisting comorbidities and hospital level.
Conclusions: Our study showed that major medical centers were safer only for ischemic stroke patients after
adjusting for patient age, sex, triage classifications and preexisting comorbidities. This finding suggests that all
patients with acute onset stroke should be sent to major medical centers for further evaluation and treatment.
[International Journal of Gerontology 2010; 4(3): 137–142]
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AMI and account for 3 billion US dollars in hospital
costs2. In addition, approximately 30−40 billion US dol-
lars is spent annually on stroke patients3, with most 
of the expenditure for hospital care. Although we have
already devised guidelines for sending AMI and stroke
patients to medical centers, there is no evidence-based
research focusing on the mortality rate of elderly AMI
and stroke patients in different levels of hospital.
Our study, using nationwide population-based data
in Taiwan, explored the mortality rate of elderly AMI and
stroke patients in major medical centers and regional
hospitals. Our findings may have major implications
for policy makers in Taiwan and internationally for
AMI and stroke care.
Materials and Methods
Database
Our data contains the original claim data of 1 million
beneficiaries enrolled in 2007, and randomly sampled
from the 2005 Registry for Beneficiaries (LHID2005) 
of the National Health Insurance Research Database
(NHIRD), which includes the registration data of every-
one who was a beneficiary of the Taiwan National
Health Insurance program. There were approximately
25.68 million individuals in this registry. All the regis-
tration and claim data of these 1 million individuals
were collected from the National Health Insurance (NHI)
program and constituted LHID2005. There was no sig-
nificant difference in the sex distribution (χ2 = 0.008,
df = 1, p = 0.05) between the patients in the LHID2005
and the original NHIRD. The NHIRD is possibly the
largest and most comprehensive population-based data
source currently available in the world, and it includes
primary diagnosis and up to 4 secondary diagnoses
which are coded by the ICD-9-CM system.
Our files included Registry for contracted medical
facilities (HOSB), Registry for beneficiaries (ID), In-
patient expenditures by admissions (DD), Details of in-
patient orders (DO) and Ambulatory care expenditures
by visits (CD).
Study sample
All hospitalized patients older than 50 years were iden-
tified from the 2007 database with the primary diagnosis
of AMI, hemorrhagic stroke, or ischemic stroke (ICD-9-
CM code 410, 430–432 or 433–438). Between January 1
and December 31, 2007, there were 338 hospital
admissions for AMI, 293 for hemorrhagic stroke, and
1,290 for ischemic stroke. Patients who were transferred
between hospitals were excluded because we could not
evaluate the cause of death between hospitals.
Key variables of interest
The control variables investigated in our study in-
cluded patient age, sex, triage classification, preexisting
comorbidities and different hospital levels. Patient age
was categorized as 50–64, 65–79 and ≥ 80 years old.
Different triage classifications for patients were recog-
nized by different payment codes. (Class I 00201A, Class
II 00202A, Class III 00203A, Class IV 00204A) The triage
classifications were categorized as severe (Class I, II) and
others (Class III, IV). Data for patients’ illness severity were
not available in this claims database, but to quantify the
patient’s preexisting comorbidity, we used the Charlson
Comorbidity Index (CCI), developed in 1987, to classify
comorbid conditions which may have affected the risk
of death from comorbid disease. It has been widely
used in many datasets for risk adjustment4–6. All the risk
factors were scaled in accordance with the CCI, which
ranged from prior congestive heart failure or myocardial
infarction (weighted as 1) to acquired immune deficiency
syndrome or a solid metastatic tumor (weighted as 6).
Statistical analysis
All the statistical analyses were performed using the
Statistical Package for the Social Sciences (SPSS 10.0;
SPSS Inc., Chicago, IL, USA). Descriptive analyses were
performed on all identified variables, including fre-
quency, percentage, mean and standard deviation. A
logistic regression analysis was then carried out to
compare the mortality between different levels of hos-
pital, adjusting for patient age, sex, preexisting comor-
bidities and hospital level.
Study hypothesis
The mortality rate for AMI and stroke in major medical
centers is significantly lower than in regional hospitals,
adjusted for age, sex, disease severity and comorbidities.
Results
The percentage of patients receiving thrombolytic
therapy for ischemic stroke was 1.5–2% in our dataset,
and there was no difference between major medical
centers and regional hospitals. The percentage receiving
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thrombolytic therapy for AMI was nearly zero in major
medical centers and about 0–10% in regional hospitals.
As shown in Figure, there were 338 hospital admis-
sions for AMI, 293 for hemorrhagic stroke, and 1,290
for ischemic stroke in 2007. Fifty patients with ischemic
stroke, 54 patients with hemorrhagic stroke and 45
patients with AMI died in hospital.
The mortality rate was 3.9% for ischemic stroke,
13.3%, for AMI, and was highest for hemorrhagic stroke
at 18.4% (Table). Age, triage classification, and hospital
level had significant effects on mortality only in patients
with ischemic stroke. In AMI patients, only age had a
significant effect on mortality. For hemorrhagic stroke,
no factor had a significant effect on mortality.
In ischemic stroke patients, the odds ratio of mor-
tality for patients older than 80 years was 2.1 times
that for 50–64-year-old patients (Table). The odds ratio
of mortality for triage I and II patients was 2.8 times
that of lower triage patients. The odds ratio of mortal-
ity for patients in major medical centers was 0.4 times
that of patients in regional hospitals. This indicates
that major medical centers are safer for ischemic
stroke patients after adjusting for patient age, sex,
triage classification, and preexisting comorbidities.
In hemorrhagic stroke patients, however, the survival
rate was not significantly different between hospitals
after adjusting for age, sex, triage classification, preex-
isting comorbidities and hospital level.
In AMI patients, the odds ratio of mortality for
patients 65–79 years old was 2.7 times that of patients
50–64 years old. The survival rate was also not signifi-
cantly different between hospitals after adjusting for
age, sex, triage classifications, preexisting comorbidi-
ties and hospital level.
Neither sex nor preexisting comorbidities were sig-
nificant factors for mortality in patients with these
three serious diseases.
Discussion
In our study, we investigated age, sex, preexisting co-
morbidities, triage classification and hospital level as
major factors for mortality rate. We found that the rate
of administration of thrombolytic therapy to ischemic
stroke patients was 1.5–2% in our dataset, and there
was no difference between major medical centers and
regional hospitals. Therefore, we believed that throm-
bolytic therapy would not have a major effect on any
difference between major medical centers and regional
hospitals, so we did not include “thrombolytic therapy”
in our model.
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Death?
Survive?
ID
Dataset in CD files Dataset in DD/DO files
Date for ER visit
Registration fee by triage classification
Hospital for ER and admission
Primary diagnosis in admission
CD
11,526 patients
> 50y/o admitted
1,290 ischemic stroke
293 hemorrhagic stroke
338 acute myocardial infarction
DD
HOSB
DO
91,704 patients
> 50y/o admitted
Died
50 ischemic stroke
54 hemorrhagic stroke
45 acute myocardial infarction
Survived
1,240 ischemic stroke
239 hemorrhagic stroke
293 acute myocardial infarction
Figure 1. Flow chart of patients analysis for AMI and stroke. AMI = acute myocardial infarction; ER = emergency room;
CD = ambulatory care expenditures by visits; DD = inpatient expenditures by admissions; DO = details of inpatient orders;
HOSB = registry for contracted medical facilities; ID = registry for beneficiaries.
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For AMI patients, the rate of administration of
thrombolytic therapy was nearly zero in major med-
ical centers, and about 0–10% in regional hospitals.
Initially, we thought that a lower rate of percutaneous
coronary intervention in regional hospitals would be
associated with a higher mortality rate for AMI pa-
tients, but in our data, there was no significant differ-
ence between the two groups of patients.
In our dataset, more than 95% of patients were
treated with aspirin, beta-blockers, and angiotensin con-
verting enzyme inhibitors, with no significant difference
between major medical centers and regional hospitals.
The length of stay for AMI patients was 8.6 ± 7.9 days,
and 99% of the cases stayed for less than 42 days. Be-
cause we only have 1 year’s data (2007), we could only
calculate the in-hospital survival rate instead of long-
term survival rate. Recent studies7,8 showed that beta-
blockers and angiotensin converting enzyme inhibitors
only increased the long-term survival rate, but did not
have a significant effect on short-term survival. Based on
that evidence, we did not think that those medications
would have a significant effect on the in-hospital mortal-
ity rate between major medical centers and regional hos-
pitals and did not include “medications” in our model.
Our study showed that major medical centers were
safer only for ischemic stroke patients after adjusting
for patient age, sex, triage classification and preexisting
comorbidities. This finding suggests that all patients
with acute onset stroke should be sent to a major med-
ical center for further evaluation and treatment. Perhaps
these centers have more manpower for taking care of
acute stroke patients. Therefore, patients with ischemic
stroke could have better survival rates in major med-
ical centers. However, most neurosurgeons agree that
the mortality rate for hemorrhagic stroke relies on the
volume of hematoma and brain damage rather than
surgery and critical care. Consequently, this may be
the reason why major medical centers do not have better
mortality rates for hemorrhagic stroke patients.
In our research for the Department of Health in 2006
on patient flow in emergency departments, we used the
original claims data of 200,000 beneficiaries who were
enrolled from 2001 to 2005. That study also demon-
strated that AMI patients had similar mortality rates in
major medical centers and regional hospitals. As most
cardiologists were trained in major medical centers,
perhaps they had enough experience and skill for taking
care of AMI patients in any hospital. Most regional hos-
pitals also had a catheterization laboratory for handling
patients with myocardial infarction. Most patients dying
from AMI did so before reaching hospital9,10. Therefore,
these are possible reasons for no significant difference
in in-hospital mortality rates of AMI patients between
major medical centers and regional hospitals.
A few study limitations need to be recognized in
our research. Firstly, although we adjusted for the two
major variables of triage classification and comorbidi-
ties (using the CCI), a potential weakness of our study
is that we could not adjust for stroke severity (although
our adjustments may serve as a considerable esti-
mation of severity). Our research should use the ideal
criteria for stroke such as the National Institutes of
Health Stroke Scale11 or the Glasgow Outcome Scale,
but they were not available in the NHIRD database.
Secondly, although severity of infarction and left ven-
tricular ejection fraction are important predictors for
mortality rate in AMI, they are also not available in the
NHIRD database. Thirdly, there could be some argu-
ments about different mortality rates for patients who
transferred from hospital to hospital. It was difficult 
to evaluate the rates, but from our research for the
Department of Health in 2006, less than 5% of stroke
patients and less than 1% of AMI patients were trans-
ferred to other hospitals. Based on this, we excluded
the patients who were transferred to other hospitals.
Fourthly, the diagnoses of AMI and stroke were sourced
from the physician/hospital reported claims. Therefore,
the accuracy of the diagnosis could be questionable.
However, the NHI regularly samples a percentage of
cases from hospitals to verify the validity of diagnosis
and quality of care through chart reviews using touring
professional teams. Hence, we consider that the valid-
ity of the diagnosis was acceptable.
Overall, our findings suggest that elderly patients
with stroke should be sent to major medical centers
for further evaluation and treatment but that elderly
patients with AMI could be sent to the nearest regional
hospital or medical center. Although this suggestion
could change policies for regionalized or centralized
programs, we need to recognize the physician–patient
load and also perform further cost effectiveness studies.
Conclusion
Our study showed that major medical centers are safer
only for ischemic stroke patients after adjusting for
patient age, sex, triage classifications, and preexisting
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comorbidities. This finding suggests that all patients
with acute onset stroke should be sent to major med-
ical centers for further evaluation and treatment. How-
ever, patients with AMI should be sent to the nearest
regional hospital or medical center.
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